Jump Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Jump Financial’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-55,659	Closed	-$9.24M	–	2267
2026 Q1	$9.24M	Buy	+55,659	New	+$9.13M	0.12%	192
2025 Q4	–	Sell	-20,145	Closed	-$1.89M	–	2133
2025 Q3	$1.89M	Buy	+20,145	New	+$1.42M	0.02%	758
2024 Q1	–	Sell	-4,274	Closed	-$521K	–	2112
2023 Q4	$521K	Buy	+4,274	New	+$327K	0.02%	1041
2023 Q2	–	Sell	-10,669	Closed	-$1.05M	–	1992
2023 Q1	$1.05M	Sell	10,669 -48,703	-82%	-$6.6M	0.04%	577
2022 Q4	$8.4M	Buy	+59,372	New	+$8.28M	0.44%	8

Other funds holding LABU

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Jump Financial's LABU Position: Q2 2026 in Review

Jump Financial sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026, closing a stake of 55,659 shares — an estimated $9.24M sold.

Jump Financial first reported a position in LABU in Q4 2022 and held it in 5 quarters. The position peaked at $9.24M in Q1 2026. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

Jump Financial reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
Jump Financial sold 55,659 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $9.24M.
Jump Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 5 quarters.
Jump Financial's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.24M in Q1 2026.
36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.